These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 9014433

  • 1. [Brain tumor and parkinsonism].
    Kondo T.
    Nihon Rinsho; 1997 Jan; 55(1):118-22. PubMed ID: 9014433
    [Abstract] [Full Text] [Related]

  • 2. [Subacute worsening of rigidity in a patient with Parkinson disease].
    Bekkelund SI, Lilleng H, Arntzen KA.
    Tidsskr Nor Laegeforen; 2008 Sep 25; 128(18):2065-6. PubMed ID: 18853522
    [Abstract] [Full Text] [Related]

  • 3. [Motor symptoms in Parkinson disease].
    Larsen JP, Beiske AG, Bekkelund SI, Dietrichs E, Tysnes OB, Vilming ST, Aasly JO.
    Tidsskr Nor Laegeforen; 2008 Sep 25; 128(18):2068-71. PubMed ID: 18846123
    [Abstract] [Full Text] [Related]

  • 4. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ, Chung SJ, Sung YH, Lee MC, Im JH.
    Mov Disord; 2006 Aug 25; 21(8):1279-81. PubMed ID: 16639728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Parkinsonism associated with neurocysticercosis.
    Sá DS, Teive HA, Troiano AR, Werneck LC.
    Parkinsonism Relat Disord; 2005 Jan 25; 11(1):69-72. PubMed ID: 15619466
    [Abstract] [Full Text] [Related]

  • 7. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep 25; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F, Cersósimo MG, Zúñiga Ramírez C.
    Mov Disord; 2006 May 25; 21(5):716-7. PubMed ID: 16463348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of advanced Parkinson's disease.
    Diamond A, Jankovic J.
    Expert Rev Neurother; 2006 Aug 25; 6(8):1181-97. PubMed ID: 16893346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA.
    Brain; 2011 Jan 25; 134(Pt 1):36-49. PubMed ID: 21059746
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.